Zhejiang Starry Pharmaceutical Co Ltd
603520
Company Profile
Business description
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Contact
No.1 Sitali Avenue
Modern Industrial Gathering District
Zhejiang Province, Xianju County
Taizhou City317306
CHNT: +86 57687718605
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,905
Stocks News & Analysis
stocks
Fair value upgrade for ASX listed fast food chain
Earnings beat lifts forecasts but long term growth questions remain.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
We’re expecting another beat-and-raise quarter, while watching the roadmap and discussions of its financing and partnership deals.
stocks
Wide moat airport share steps up its investments
Profits flatten as airport ramps up redevelopment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,361.60 | 37.10 | 0.40% |
| CAC 40 | 8,453.01 | 31.42 | -0.37% |
| DAX 40 | 26,106.60 | 29.96 | -0.11% |
| Dow JONES (US) | 53,417.16 | 140.15 | 0.26% |
| FTSE 100 | 10,854.32 | 37.76 | 0.35% |
| HKSE | 25,507.00 | 10.33 | -0.04% |
| NASDAQ | 25,980.19 | 200.27 | -0.76% |
| Nikkei 225 | 65,591.10 | 63.01 | 0.10% |
| NZX 50 Index | 13,975.83 | 93.95 | 0.68% |
| S&P 500 | 7,652.86 | 21.51 | -0.28% |
| S&P/ASX 200 | 9,154.10 | 43.80 | 0.48% |
| SSE Composite Index | 3,883.47 | 1.46 | 0.04% |